# Impact of CBD and hemp oil use on drug test results: a systematic review

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/research/cbd-for-drug-testing-systematic-review/
> **Published:** 2026-10-15T12:19:37-04:00 | **Last Modified / Clinically Audited:** 2026-10-20T13:53:27-04:00
> **Clinical Summary:** This review looked at many earlier studies to see whether using CBD products or hemp oil can cause a person to fail a drug test for cannabis.

---

Background: Hemp-derived products, especially CBD oil and hemp oil, have shown a notable increase in use. Concerns exist about unintended cannabinoid findings (THC, 11-OH-THC, THC-COOH) on drug tests in workplace, road safety, and anti-doping settings, since many ‘THC-free’ products may contain trace THC and oversight of CBD oils is heterogeneous. Methods: Systematic review following PRISMA guidelines of studies published in English from March 2014 to March 2024, searched in PubMed, WOS and SCOPUS. Results: Of 477 records, 12 studies met inclusion criteria. Eight evaluated whether CBD or hemp oil use yields positive cannabinoid findings in biological materials; five reported no results above the limit of detection or cut-off, though trace or near-limit levels were seen. Four studies evaluated conversion of CBD to THC in human metabolism; two of four found no biotransformation or extraction-induced transformation. Conclusions: Positive results arise mainly from product content (undeclared or excessive THC, mislabeling, contamination), matrix, administration route, and analytical sensitivity/specificity. CBD conversion to THC during manufacturing or in the body may pose legal risks in zero-tolerance jurisdictions.

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).